Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab

ClinicalTrials.gov ID: NCT01927757

Public ClinicalTrials.gov record NCT01927757. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single Arm Trial to Evaluate the Efficacy of Etanercept in Moderate to Severe Rheumatoid Arthritis Patients Who Failed to Respond or Lost a Satisfactory Response to Treatment With Adalimumab When Used as Their First Biologic Agent

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the efficacy of etanercept in adults with moderate-to-severe rheumatoid arthritis (RA) who did not respond to or lost a satisfactory response to adalimumab when used as their first biologic agent.

Study identification

NCT ID
NCT01927757
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Amgen
Industry
Enrollment
90 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 6, 2013 (Actual)
Primary completion
Jun 11, 2015 (Actual)
Completion
Jun 11, 2015 (Actual)
Last update posted
Jan 30, 2018

2013 – 2015

United States locations

U.S. sites
32
U.S. states
19
U.S. cities
32
Facility City State ZIP Site status
Research Site Tuscaloosa Alabama 35406 —
Research Site Scottsdale Arizona 85258 —
Research Site Covina California 91723 —
Research Site Hemet California 92543 —
Research Site Murrieta California 92563 —
Research Site San Diego California 92108 —
Research Site Victorville California 92395 —
Research Site Denver Colorado 80230 —
Research Site Brandon Florida 33511 —
Research Site Dunedin Florida 34698 —
Research Site Largo Florida 33774 —
Research Site Palm Harbor Florida 34684 —
Research Site Tampa Florida 33609 —
Research Site Lawrenceville Georgia 30046 —
Research Site Bowling Green Kentucky 42101 —
Research Site Paducah Kentucky 42003 —
Research Site Fall River Massachusetts 02720 —
Research Site Battle Creek Michigan 49017 —
Research Site Lincoln Nebraska 68516 —
Research Site Smithtown New York 11787 —
Research Site Charlotte North Carolina 28210 —
Research Site Middleburg Heights Ohio 44130 —
Research Site Duncansville Pennsylvania 16635 —
Research Site Hixson Tennessee 37343 —
Research Site Austin Texas 78731 —
Research Site Corpus Christi Texas 78404 —
Research Site Houston Texas 77034 —
Research Site Victoria Texas 77901 —
Research Site Chesapeake Virginia 23320 —
Research Site Roanoke Virginia 24016 —
Research Site Seattle Washington 98133 —
Research Site Clarksburg West Virginia 26301 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01927757, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2018 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01927757 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →